Global measles outbreaks are still a travel and community risk in 2026. Here is what that means for families.

WHO’s Bangladesh outbreak update shows measles is still active globally in 2026, and travel-related cases can still spark U.S. spread where vaccination is low.

Measles is still a real travel and community health risk in 2026, even in places that do not have constant local spread. The practical takeaway for families is simple: if you or your child are not up to date on the MMR vaccine, check before international travel, and do not ignore symptoms after a trip or a known exposure.

The latest reminder comes from Bangladesh. In an April 15 update, the World Health Organization said the country was dealing with a large, fast-moving outbreak, with transmission reported in most districts and many cases in very young children. WHO said about 80% of cases were in children younger than 5, especially children under 2 and infants under 9 months. The agency linked the outbreak to immunity gaps, declining routine immunization, high population movement, and vaccine supply strain.

Recent outbreak news: why Bangladesh matters now

Bangladesh is not a stand-in for every country, and it does not mean the same level of risk exists everywhere. But it is a clear example of what measles can do when enough people are left without protection. WHO reported more than 18,000 suspected cases between March 15 and April 14, 2026, including nearly 2,900 laboratory-confirmed cases. It also said the outbreak had put pressure on hospitals and prompted a phased measles-rubella vaccination campaign for young children.

That matters beyond one country because measles spreads very easily. It is one of the most contagious infectious diseases known. CDC researchers have noted that larger U.S. outbreaks typically start when measles is imported by a traveler and then reaches a close-knit community with lower vaccination coverage. The Infectious Diseases Society of America also notes that up to 9 in 10 people without immunity can become infected after exposure.

The bigger picture: some progress, but uneven protection

The global story is mixed. A WHO global update published in late 2025 said measles deaths had fallen sharply since 2000, but cases were still surging. The agency estimated about 11 million infections worldwide in 2024, which was above pre-pandemic 2019 levels. It also reported that first-dose measles vaccine coverage was about 84% and second-dose coverage about 76% in 2024, both below the level usually needed to keep outbreaks from taking hold.

There are also signs of improvement in some places. WHO and UNICEF said in February 2026 that measles cases in Europe and Central Asia fell substantially in 2025 compared with 2024. Still, they warned that the decline was fragile, that some countries saw increases, and that cases were still being detected in 2026. In other words, better numbers in one region do not erase the broader risk when coverage remains uneven.

The often-cited 95% benchmark can help explain why this keeps happening. Public health agencies use it as the approximate community coverage level needed to limit sustained measles spread. It is not a hard guarantee that no cases will occur, but it is the level commonly used to show how much protection a community usually needs to keep the virus from moving from one person to the next for long.

Why outbreaks abroad still matter in the United States

For U.S. readers, the key point is that measles elimination is not the same as eradication. CDC says elimination means a country has stopped continuous local transmission for 12 months or longer. It does not mean zero cases, and it does not mean travelers cannot bring the virus back.

CDC’s global measles program says cases anywhere in the world can threaten communities where coverage falls below 95%. A CDC surveillance report in MMWR showed how that can happen in real life. During the first 16 weeks of 2025, the United States recorded 800 measles cases, most linked to outbreaks in communities with low vaccination coverage. The report found that almost all patients were unvaccinated or had unknown vaccination status. It also said most imported cases occurred in U.S. residents returning from travel while infectious.

That report is useful context, but it is still a snapshot from early 2025, not a complete picture of long-term U.S. risk. Outbreak patterns can change quickly by season, travel volume, and local vaccination levels. The larger lesson is the more important one: global spread can become local spread when immunity gaps line up with travel.

What families should do before travel

CDC’s travel guidance is straightforward. People traveling internationally should be fully vaccinated against measles at least two weeks before departure when possible.

  • Infants 6 through 11 months: may need an early MMR dose before international travel.
  • Children 12 months and older: should be up to date, which usually means two appropriately timed doses.
  • Teens and adults without evidence of immunity: may also need vaccination before travel.

Families should not try to create their own schedule from a news article, especially for infants, pregnancy, or immune system conditions. If travel is coming up soon, a pediatrician, primary care clinician, travel clinic, or local health department can help sort out what is recommended.

Who is most vulnerable

The people at highest risk are not the same in every situation, but several groups stand out:

  • unvaccinated children
  • infants who are too young for routine protection
  • pregnant people without immunity
  • people with weakened immune systems who may not be able to receive MMR vaccination

CDC notes that high community vaccination coverage helps protect people who cannot safely get vaccinated because of age, pregnancy, or immunocompromising conditions. That is one reason public health officials focus so much on community coverage, not just individual choice.

Symptoms to watch for and when to seek care

Measles often starts with fever, cough, runny nose, and red eyes, followed by a rash. If these symptoms appear after international travel, after a known exposure, or during a local outbreak, call a clinician right away.

It is best to call ahead before going to a clinic, urgent care center, or emergency department. Measles can spread through the air, so a phone call first can help the office protect other patients and tell you where to go.

Bottom line

Global progress against measles is real, but it is uneven. Bangladesh is one recent example of how quickly the virus can spread when immunity gaps widen. For U.S. families, that means outbreaks abroad still matter at home. Travelers can import measles, and communities with lower vaccination coverage remain vulnerable to local spread.

What this means for readers is practical, not alarmist: check MMR status before international travel, ask early if an infant or pregnant family member needs special planning, and call for medical advice if fever, cough, red eyes, and rash show up after travel or exposure. Measles is still preventable, but prevention depends on keeping vaccination coverage high enough for the whole community.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.